Factors | Multivariable analysis | |
---|---|---|
Odds ratio (95% CI) | P value | |
Age | 1.011 (0.952–1.074) | 0.721 |
Male | 4.320 (0.611–30.564) | 0.143 |
BMI | 0.978 (0.845–1.133) | 0.770 |
Diabetes mellitus | 2.483 (0.347–17.764) | 0.365 |
Dyslipidemia | 11.773 (1.785–77.641) | 0.010 |
Obstructive sleep apnea | 1.505 (0.069–32.933) | 0.795 |
Coronary artery disease | 0.031 (0.001–0.924) | 0.045 |
Diuretics | 0.224 (0.026–1.938) | 0.174 |
CCBs | 1.788 (0.365–8.757) | 0.473 |
ACEIs | 0.076 (0.010–0.572) | 0.012 |
ARBs | 0.423 (0.081–2.197) | 0.306 |
Beta-blockers | 2.091 (0.486–9.003) | 0.322 |
Peripheral alpha-1 blockers | 1.446 (0.175–11.932) | 0.732 |
Central acting alpha-2 agonists | 0.737 (0.028–19.498) | 0.855 |
Direct vasodilators | 0.038 (0.002–0.743) | 0.031 |
Evening drug administration | 1.584 (0.395–6.355) | 0.517 |
Average office SBP | 1.052 (0.992–1.115) | 0.092 |
Average office DBP | 0.886 (0.818–0.959) | 0.003 |
Hemoglobin | 0.843 (0.507–1.399) | 0.508 |
RDW | 0.670 (0.401–1.120) | 0.126 |
MCV | 0.941 (0.842–1.052) | 0.287 |
NLR | 0.949 (0.386–2.331) | 0.909 |
PLR | 1.001 (0.995–1.007) | 0.760 |
Fasting plasma glucose | 0.972 (0.934–1.012) | 0.168 |
Cholesterol | 0.987 (0.910–1.069) | 0.744 |
Triglyceride | 0.996 (0.971–1.024) | 0.818 |
HDL-cholesterol | 0.980 (0.893–1.075) | 0.672 |
LDL-cholesterol | 1.014 (0.939–1.095) | 0.720 |
Uric acid | 0.615 (0.407–0.932) | 0.022 |
Abnormal proteinuria | 1.552 (0.306–7.871) | 0.596 |
eGFR | 0.999 (0.953–1.047) | 0.966 |